He summed up our current funding status (these numbers are also on the funding commitments page of our website):
About $1.87 billion in grants have been approved by the Independent Citizens Oversight Committee, which governs the San Francisco-based agency. Of that amount, about $1.59 billion has been allocated after staff review. And $1.19 billion has actually been paid out.As he correctly points out, most of that funding has so far gone to researchers trying to better understand the nature of stem cells--information that is needed if we are going to put those cells to work treating disease (here's the complete list of awards).
In recent years, that early research has paid off in the form of therapies being tested in clinical trials. Right now, nine clinical trials underway are either being directly funded by CIRM (for heart disease and HIV/AIDS) or came out of work we funded. Here's his list:
Fikes went on to quote Lawrence Goldstein, who directs UCSD's stem cell program, talking about the pace of research:
The full story has more about the agency and our plans for the future.